↓ Skip to main content

Correction to: Bispecific CAR-T cells targeting both CD19 and CD22 for therapy of adults with relapsed or refractory B cell acute lymphoblastic leukemia

Overview of attention for article published in Journal of Hematology & Oncology, May 2020
Altmetric Badge

Mentioned by

twitter
1 X user

Readers on

mendeley
23 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Correction to: Bispecific CAR-T cells targeting both CD19 and CD22 for therapy of adults with relapsed or refractory B cell acute lymphoblastic leukemia
Published in
Journal of Hematology & Oncology, May 2020
DOI 10.1186/s13045-020-00878-2
Pubmed ID
Authors

Hanren Dai, Zhiqiang Wu, Hejin Jia, Chuan Tong, Yelei Guo, Dongdong Ti, Xiao Han, Yang Liu, Wenying Zhang, Chunmeng Wang, Yajing Zhang, Meixia Chen, Qingming Yang, Yao Wang, Weidong Han

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 23 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 23 100%

Demographic breakdown

Readers by professional status Count As %
Unspecified 3 13%
Student > Ph. D. Student 3 13%
Student > Bachelor 2 9%
Researcher 2 9%
Student > Master 2 9%
Other 1 4%
Unknown 10 43%
Readers by discipline Count As %
Immunology and Microbiology 4 17%
Unspecified 3 13%
Biochemistry, Genetics and Molecular Biology 2 9%
Business, Management and Accounting 1 4%
Chemical Engineering 1 4%
Other 2 9%
Unknown 10 43%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 19 May 2020.
All research outputs
#20,618,687
of 23,208,901 outputs
Outputs from Journal of Hematology & Oncology
#1,048
of 1,204 outputs
Outputs of similar age
#333,679
of 389,743 outputs
Outputs of similar age from Journal of Hematology & Oncology
#38
of 44 outputs
Altmetric has tracked 23,208,901 research outputs across all sources so far. This one is in the 1st percentile – i.e., 1% of other outputs scored the same or lower than it.
So far Altmetric has tracked 1,204 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 10.4. This one is in the 1st percentile – i.e., 1% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 389,743 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 44 others from the same source and published within six weeks on either side of this one. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.